1. Home
  2. LOGC vs MDWD Comparison

LOGC vs MDWD Comparison

Compare LOGC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOGC
  • MDWD
  • Stock Information
  • Founded
  • LOGC 2010
  • MDWD 2000
  • Country
  • LOGC United States
  • MDWD Israel
  • Employees
  • LOGC N/A
  • MDWD N/A
  • Industry
  • LOGC Catalog/Specialty Distribution
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • LOGC Consumer Discretionary
  • MDWD Health Care
  • Exchange
  • LOGC Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • LOGC 186.6M
  • MDWD 184.8M
  • IPO Year
  • LOGC 2020
  • MDWD 2014
  • Fundamental
  • Price
  • LOGC $6.74
  • MDWD $16.51
  • Analyst Decision
  • LOGC
  • MDWD Strong Buy
  • Analyst Count
  • LOGC 0
  • MDWD 1
  • Target Price
  • LOGC N/A
  • MDWD $25.00
  • AVG Volume (30 Days)
  • LOGC 266.9K
  • MDWD 63.4K
  • Earning Date
  • LOGC 11-07-2024
  • MDWD 11-26-2024
  • Dividend Yield
  • LOGC N/A
  • MDWD N/A
  • EPS Growth
  • LOGC N/A
  • MDWD N/A
  • EPS
  • LOGC N/A
  • MDWD N/A
  • Revenue
  • LOGC $96,000,000.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • LOGC N/A
  • MDWD $10.37
  • Revenue Next Year
  • LOGC $422.91
  • MDWD $26.36
  • P/E Ratio
  • LOGC N/A
  • MDWD N/A
  • Revenue Growth
  • LOGC N/A
  • MDWD N/A
  • 52 Week Low
  • LOGC $4.01
  • MDWD $10.06
  • 52 Week High
  • LOGC $8.24
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • LOGC 40.45
  • MDWD 48.11
  • Support Level
  • LOGC $7.03
  • MDWD $16.80
  • Resistance Level
  • LOGC $8.21
  • MDWD $18.12
  • Average True Range (ATR)
  • LOGC 0.37
  • MDWD 0.75
  • MACD
  • LOGC -0.16
  • MDWD -0.03
  • Stochastic Oscillator
  • LOGC 12.98
  • MDWD 25.57

About LOGC ContextLogic Inc.

ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives a majority of its revenue from Europe and also has a presence in North America; South America, and other countries.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: